🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 23 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/01/2014 | 107,17 | 107,51 | 105,04 | 106,32 | +0,65% | 2,30% | 475.100 |
| 29/01/2014 | 107,28 | 107,81 | 104,92 | 105,63 | -1,79% | 2,69% | 415.500 |
| 28/01/2014 | 106,04 | 108,21 | 104,50 | 107,56 | +1,75% | 3,50% | 415.000 |
| 27/01/2014 | 107,66 | 107,66 | 102,83 | 105,71 | -1,70% | 4,49% | 625.400 |
| 24/01/2014 | 111,76 | 111,76 | 107,06 | 107,54 | -4,74% | 4,21% | 580.000 |
| 23/01/2014 | 113,38 | 114,20 | 111,29 | 112,89 | -0,41% | 2,57% | 462.600 |
| 22/01/2014 | 114,11 | 115,00 | 112,45 | 113,36 | -0,03% | 2,23% | 410.400 |
| 21/01/2014 | 112,52 | 113,78 | 111,13 | 113,39 | +2,23% | 2,36% | 645.700 |
| 17/01/2014 | 113,47 | 113,47 | 110,57 | 110,92 | -2,12% | 2,56% | 534.400 |
| 16/01/2014 | 109,91 | 113,83 | 109,56 | 113,32 | +2,56% | 3,88% | 869.100 |
| 15/01/2014 | 111,09 | 112,54 | 109,53 | 110,49 | -0,32% | 2,71% | 476.400 |
| 14/01/2014 | 108,88 | 111,51 | 107,63 | 110,85 | +2,40% | 3,56% | 1.033.000 |
| 13/01/2014 | 110,90 | 113,75 | 106,56 | 108,25 | -2,47% | 6,48% | 922.200 |
| 10/01/2014 | 109,66 | 111,08 | 108,26 | 110,99 | +2,07% | 2,57% | 788.100 |
| 09/01/2014 | 110,00 | 110,97 | 107,21 | 108,74 | -0,88% | 3,42% | 710.200 |
| 08/01/2014 | 110,15 | 110,27 | 108,96 | 109,70 | -0,66% | 1,19% | 751.600 |
| 07/01/2014 | 112,30 | 112,62 | 109,10 | 110,43 | -0,85% | 3,13% | 693.300 |
| 06/01/2014 | 111,92 | 112,75 | 110,11 | 111,38 | +0,06% | 2,36% | 807.600 |
| 03/01/2014 | 111,25 | 111,79 | 109,86 | 111,31 | +0,37% | 1,73% | 569.100 |
| 02/01/2014 | 112,79 | 112,97 | 109,70 | 110,90 | -1,93% | 2,90% | 608.400 |
| 31/12/2013 | 113,78 | 114,70 | 111,91 | 113,08 | +0,67% | 2,45% | 511.800 |
| 30/12/2013 | 113,45 | 114,47 | 111,02 | 112,33 | -1,09% | 3,04% | 453.900 |
| 27/12/2013 | 111,99 | 115,00 | 111,93 | 113,57 | +1,41% | 2,74% | 661.600 |
| 26/12/2013 | 112,56 | 114,06 | 111,27 | 111,99 | -0,76% | 2,48% | 831.600 |
| 24/12/2013 | 114,35 | 116,65 | 112,52 | 112,85 | -1,45% | 3,61% | 1.041.300 |
| 23/12/2013 | 104,64 | 115,48 | 103,08 | 114,51 | +30,36% | 11,85% | 4.882.500 |
| 20/12/2013 | 87,03 | 88,10 | 85,76 | 87,84 | +1,24% | 2,69% | 918.900 |
| 19/12/2013 | 88,58 | 88,58 | 85,76 | 86,76 | -2,07% | 3,18% | 453.800 |
| 18/12/2013 | 86,19 | 88,89 | 85,40 | 88,59 | +3,14% | 4,05% | 580.700 |
| 17/12/2013 | 88,50 | 88,50 | 85,73 | 85,89 | -2,88% | 3,13% | 647.500 |